Stock listing

KRYS Stock Price, News, Filings & Events — Krystal Biotech, Inc.

Selected listing: KRYS · BX · CHF · CH

KRYS:BX is the public listing for Krystal Biotech, Inc., a company dedicated to developing innovative gene therapies for dermatological conditions. With a market capitalization of approximately $10.78 billion, Krystal Biotech is focused on addressing unmet medical needs using its proprietary technology platform. Recent news and filings may provide insights into the company's ongoing projects and advancements in gene therapy. Investors and stakeholders can stay informed about upcoming events that may impact the company's market presence.

KRYS:BXCHFCHUpdated July 21, 2026
Krystal Biotech, Inc. logo
Ticker
KRYS:BX
Asset type
Stock
Market cap
$10.78B
Sector
Health Technology
Industry
Biotechnology
Exchange
BX
Currency
CHF

Krystal Biotech, Inc. KRYS:BX stock context

KRYS:BX is the public listing for Krystal Biotech, Inc., a company dedicated to developing innovative gene therapies for dermatological conditions. With a market capitalization of approximately $10.78 billion, Krystal Biotech is focused on addressing unmet medical needs using its proprietary technology platform. Recent news and filings may provide insights into the company's ongoing projects and advancements in gene therapy. Investors and stakeholders can stay informed about upcoming events that may impact the company's market presence.

Research Krystal Biotech, Inc.

Alternate listings